Plain-English translation of NCT07674758 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows patients with Duchenne muscular dystrophy, Becker muscular dystrophy, or who carry the muscular dystrophy gene to learn more about heart problems that develop in these conditions. The study collects heart imaging scans (called CMR scans) and medical information over time to understand how heart disease progresses and what warning signs predict serious problems.
Heart disease is the leading cause of death in people with these forms of muscular dystrophy, yet we don't have good ways to predict who will get sicker faster or which patients are at highest risk. This study aims to find those early warning signs so that doctors can better treat and monitor heart disease in these patients, and so that new treatments can be tested more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will continue to receive your normal heart care and imaging at one of the 12 participating medical centers. The study collects your heart imaging scans (performed every 1–2 years as part of your regular care) and your medical records — there are no extra visits or procedures required. Researchers will use this information to build a database that helps them understand how heart disease develops in muscular dystrophy and find better ways to predict and treat it.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States